mirtazapine has been researched along with Palmoplantaris Pustulosis in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psoriasis is a common chronic inflammatory skin disease observed in about 1-3% of the general population." | 2.53 | Itch in Psoriasis Management. ( Reich, A; Szepietowski, JC, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szepietowski, JC | 1 |
| Reich, A | 1 |
| Dawn, A | 1 |
| Yosipovitch, G | 1 |
2 reviews available for mirtazapine and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Itch in Psoriasis Management.
Topics: Adaptation, Psychological; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Doxepin; | 2016 |
Treating itch in psoriasis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipr | 2006 |